Medical Communications

A Brazilian study has assessed the effect of early treatment with fluvoxamine on the risk of emergency care and hospitalisation …

Genentech have announced that Susvimo, previously known as the port delivery system, is the fist wet age-related macular degeneration (AMD) …

Clinical stage biopharmaceutical company, XBiotech, plans to test its new True Human™ antibody therapy for reducing brain injury after stroke, …

The US FDA has approved of the Roche VENTANA PD-L1 Assay as a companion diagnostic for Tecentriq® in non-small cell …

Global independent pharmaceutical group, Servier, has announced that the primary objective (progression free survival) of the Phase III SOLSTICE trial …

The US Centers for Disease Control and Prevention (CDC) has backed a plan to allow COVID-19 vaccine boosters for recipients …

The US FDA has issued an Emergency Use Authorisation (EUA) for Xtrava’s SPERA™ COVID-19 Ag Test. The easy-to-use, rapid lateral …

The first Indian anti-cancer drug, Abiraterone Acetate API, has launched in China, by Dr Reddy’s Laboratories. This breakthrough was announced …

The FDA Advisory Committee has unanimously voted in support of emergency use for a booster dose of Moderna’s COVID-19 vaccine …

The human medicines committee of the EMA has begun the rolling review of AstraZeneca’s antibody-based COVID-19 therapy, the first protective …

A unit of Abbott Laboratories is recalling two COVID-19 lab test kits over concerns they can potentially issue false positives, …

A 150-page report published on Tuesday by the House of Commons, Science and Technology Committee, and Health and Social Care …

AuroBindo Pharma Ltd and MSD Laboratories plan to end their respective trials of MSD’s experimental antiviral drug molnupiravir in moderate …

Leading manufacturing organisation Samsung Biologics, alongside drug development company Enzolytics, have announced the signing of a strategic CDMO partnership agreement. …

Talem Therapeutics, subsidiary of Immunoprecise Antibodies Ltd (IPA), and the Pierre Fabre pharmaceutical group have announced a multi-target research collaboration, …